Results

Total Results: 423 records

Showing results for "aspirin".

101. Clinical Practice Update: Notable USPSTF 2022 FINAL Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/files/Partner_Pilot_Document_12_20.pdf
     December 31, 2022 - www.uspreventiveservicestaskforce.org/apps/ GRADE CHANGE https://www.uspreventiveservicestaskforce.org/uspstf/ ASPIRIN … risk for developing heart disease or stroke should decide together with their clinician if starting aspirin … D Grade People who are 60 years and older should not start taking aspirin to prevent a first heart … statin-use-in-adults-preventive-medication https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication … www.uspreventiveservicestaskforce.org https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication

102. Draft Evidence Review: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
     October 12, 2021 - in progress Draft Evidence Review Aspirin Use to Prevent Cardiovascular Disease: Preventive … Draft Evidence Review (PDF) Return to In Progress page Expand All Aspirin

103. Draft Evidence Review: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
     February 23, 2021 - in progress Draft Evidence Review Aspirin Use to Prevent Preeclampsia and Related Morbidity … Draft Evidence Review (PDF) Return to In Progress page Expand All Aspirin

104. Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-modeling-report/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
     October 12, 2021 - in progress Draft Modeling Report Aspirin Use to Prevent Cardiovascular Disease: Preventive … Draft Modeling Report (PDF) Return to In Progress page Expand All Aspirin

105. Public Comment on Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-aspirin-use-prevent-preeclampsia-and-related-morbidity-and-mortality
     July 17, 2019 - Public Comment on Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and … Preventive Services Task Force posted today a draft research plan on aspirin use to prevent preeclampsia

106. Public Comment on Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-aspirin-use-prevent-cardiovascular-disease-and-colorectal-cancer
     February 26, 2020 - Public Comment on Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer … Preventive Services Task Force posted today a draft research plan on aspirin use to prevent cardiovascular

107. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-research-plan-aspirin-use-prevent-cardiovascular-disease-and-colorectal-cancer
     May 14, 2020 - Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer … Preventive Services Task Force posted today a final research plan on aspirin use to prevent cardiovascular

108. Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-research-plan-aspirin-use-prevent-preeclampsia-and-related-morbidity-and-mortality
     September 26, 2019 - Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality … Preventive Services Task Force posted today a final research plan on aspirin use to prevent preeclampsia

109. Final Evidence Review: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - to WhatsApp Share to Email Print Final Evidence Review Aspirin … Evidence Review (PDF) Return to Recommendation Expand All Panel 1 Aspirin

110. Final Modeling Report: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - to WhatsApp Share to Email Print Final Modeling Report Aspirin … Modeling Report (PDF) Return to Recommendation Expand All Panel 1 Aspirin

111. Aspirin for Prevention of Preeclampsia Morbidity and Mortality Draft Recommendation Statement | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/aspirin-use-preeclampsia-prevention-morbidity-mortality-draft-recommendation-statement
     March 22, 2021 - 1 Current: Terms and Conditions 2 Page 1 3 Page 2 4 Contact Information 5 Complete …

112. Aspirin Use for Prevention of Preeclampsia Morbidity and Mortality Draft Evidence Review | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/aspirin-use-prevention-preeclampsia-morbidity-mortality-draft-evidence-review
     March 22, 2021 - 1 Current: Terms and Conditions 2 Page 1 3 Page 2 4 Contact Information 5 Complete …

113. Archived: Carotid Artery Stenosis: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
     January 01, 1996 - plus carotid endarterectomy or aspirin therapy alone. … or to aspirin alone. … A randomized trial of aspirin and sulfinpyrazone in threatened stroke. … United Kingdom transient ischemic attack (UK-TIA) aspirin trial: interim results. … Final report on the aspirin component of the ongoing Physicians' Health Study.

114. Evidence Summary: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/peripheral-artery-disease-in-adults-screening-with-the-ankle-brachial-index
     July 10, 2018 - in Scotland, examined the effectiveness of aspirin in populations with a low ABI. 29 , 30 The Aspirin … Intervention groups in both trials received 100 mg of oral aspirin daily; aspirin was enteric coated … for the group taking aspirin compared with the group not taking aspirin. … Evidence for the harms of treatment are limited to the 2 trials of aspirin and suggest that aspirin may … The 2 aspirin trials demonstrated that aspirin is not effective in reducing composite CVD morbidity or

115. Recommendation: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication
     May 07, 2020 - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication An Update … See Current Final Recommendation Statement for Aspirin Use to Prevent Cardiovascular Disease and Colorectal

116. Public Comment on Draft Research Plan: Aspirin Use for the Primary Prevention of Cardiovascular Events | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-aspirin-use-primary-prevention-cardiovascular-events
     August 07, 2013 - Public Comment on Draft Research Plan: Aspirin Use for the Primary Prevention of Cardiovascular Events … Preventive Services Task Force posted today its draft Research Plan on aspirin use for the primary prevention

117. Public Comment on Draft Research Plan: Aspirin Use to Prevent Colorectal Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-aspirin-use-prevent-colorectal-cancer
     July 10, 2013 - Public Comment on Draft Research Plan: Aspirin Use to Prevent Colorectal Cancer Share to … Preventive Services Task Force posted today its draft Research Plan on aspirin use to prevent colorectal

118. Public Comment on Draft Recommendation Statement and Draft Evidence Summaries: Aspirin to Prevent Cardiovascular Disease and Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-summaries-aspirin-prevent-cardiovascular-disease-and-cancer
     October 12, 2015 - Public Comment on Draft Recommendation Statement and Draft Evidence Summaries: Aspirin to Prevent Cardiovascular … Preventive Services Task Force posted today a draft recommendation statement and draft evidence summaries on aspirin

119. Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-low-dose-aspirin-prevention-morbidity-and-mortality-preeclampsia
     May 05, 2014 - Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and … Preventive Services Task Force posted today its draft Recommendation Statement on low-dose aspirin for

120. Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/fXJESRpEwCmPh-FQobvtAY
     July 10, 2018 - Intervention groups in both trials received 100 mg of oral aspirin daily; aspirin was enteric coated … lyzed for the group taking aspirin compared with the group not taking aspirin. … Evidence for the harms of treatment are limited to the 2 trials of aspirin and suggest that aspirin may … Evidence for treatment benefit consists of 2 trials of aspirin and 2 trials of exercise; 1 of the aspirin … The 2 aspirin trials demonstrated that aspirin is not effec- tive in reducing composite CVD morbidity